Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

PUBLICATION DATE

10 results
Display

Clinicopathological Features and Survival of Patients with Gastric Cancer with a Family History: a Large Analysis of 2,736 Patients with Gastric Cancer

Jeong O, Jung MR, Park YK, Ryu SY

PURPOSE: Previous studies indicated conflicting results regarding the prognosis of gastric cancer with a family history (FHX). This study aimed to determine the clinicopathological features and survival of patients with...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Five-year Survival Associated with Stage I Gastric Cancer after Resection of Early Recurrence at Nodal Station No. 14v: a Case Report

Abe I, Kinoshita , Kaito A, Sunagawa H, Watanabe M, Sugita S, Tonouchi A, Sato R

The role of nodal station No. 14v (along the superior mesenteric vein) in lymphadenectomy for distal gastric cancer remains elusive. A 73-year-old woman underwent endoscopic submucosal dissection for gastric cancer,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Botulinum Toxin Injection for the Treatment of Delayed Gastric Emptying Following Pylorus-Preserving Gastrectomy: an Initial Experience

Lee JH, Kim CG, Kim YW, Choi IJ, Lee JY, Cho SJ, Kim YI, Eom BW, Yoon HM, Ryu KW

PURPOSE: To report our experience of endoscopic botulinum toxin injection in patients who experienced severe delayed gastric emptying after pylorus-preserving gastrectomy (PPG). MATERIALS AND METHODS: We reviewed the medical records of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Chronological Changes in Quality of Life after Distal Gastrectomy for Gastric Cancer

Park KB, Lee SS, Kwon OK, Chung HY, Yu W

PURPOSE: Patient quality of life (QoL) may be severely disrupted following distal gastrectomy for gastric cancer. This issue should be addressed to improve postoperative care. MATERIALS AND METHODS: QoL data from...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Gastric Adenocarcinoma Secondary to Primary Gastric Diffuse Large B-cell Lymphoma

Sakr R, Massoud M, Aftimos G, Chahine G

Despite the decreasing incidence and mortality from gastric cancer, it remains a major health problem worldwide. Ninety percent of cases are adenocarcinomas. Here, we report a case of gastric adenocarcinoma...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Multiple Primary Malignancies in Patients with Multiple Early Gastric Cancer

Kim DH, Kim SM, Choi MG, Sohn TS, Bae JM, Kim S

PURPOSE: This study aimed to investigate the correlation between multiple early gastric cancer (MEGC) and multiple primary malignancies during the follow-up of patients with gastrectomy. MATERIALS AND METHODS: The number of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Actual 5-Year Nutritional Outcomes of Patients with Gastric Cancer

Kim KH, Park DJ, Park YS, Ahn SH, Park DJ, Kim HH

PURPOSE: In this study, we aimed to evaluate the rarely reported long-term nutritional results of patients with gastric cancer after curative gastrectomy. MATERIALS AND METHODS: We retrospectively reviewed the prospectively collected...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effect of a Proton Pump Inhibitor on Tumor Bleeding Prevention in Unresectable Gastric Cancer Patients: a Double-Blind, Randomized, Placebo-Controlled Trial

Kim YI, Kim MJ, Park SR, Kim HK, Cho SJ, Lee JY, Kim CG, Kim GH, Park MI, Nam BH, Park YI, Choi IJ

PURPOSE: Tumor bleeding is a major complication in inoperable gastric cancer. The study aim was to investigate the effects of proton pump inhibitor (PPI) treatment for the prevention of gastric...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Real-time Vessel Navigation Using Indocyanine Green Fluorescence during Robotic or Laparoscopic Gastrectomy for Gastric Cancer

Kim M, Son SY, Cui LH, Shin HJ, Hur H, Han SU

PURPOSE: Identification of the infrapyloric artery (IPA) type is a key component of pylorus-preserving gastrectomy. As the indocyanine green (ICG) fluorescence technique is known to help visualize blood vessels and...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Prognostic Factor Analysis of Overall Survival in Gastric Cancer from Two Phase III Studies of Second-line Ramucirumab (REGARD and RAINBOW) Using Pooled Patient Data

Fuchs CS, Muro K, Tomasek J, Van Cutsem E, Cho JY, Oh SC, Safran H, Bodoky G, Chau I, Shimada Y, Al-Batran , Passalacqua R, Ohtsu A, Emig M, Ferry D, Chandrawansa K, Hsu Y, Sashegyi A, Liepa AM, Wilke H

PURPOSE: To identify baseline prognostic factors for survival in patients with disease progression, during or after chemotherapy for the treatment of advanced gastric or gastroesophageal junction (GEJ) cancer. MATERIALS AND METHODS:...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr